Pharmaceutical giant Pfizer has received U.S. approval for a gene therapy against a form of hemophilia, a rare and inherited blood clotting disorder, the company said Friday. Beqvez, which is given as a single intravenous infusion, was shown in a clinical trial of 45 people to be better at (...)
Site référencé: Raw Story
Raw Story
‘Going to lose my daughter !' GOP rep confronted with mom’s heartbreaking warning
3/07/2025
ICE’s record cash infusion has expert wondering if they can even spend it all
3/07/2025
Murkowski roasted as megabill she didn't want as 'final product' heads to Trump
3/07/2025
'Rot in hell' : Mike Lawler scorched after touting GOP budget vote on Fox News
3/07/2025
'Audacious !' Mike Johnson pats himself on back for passing megabill 'day early'
3/07/2025
'Won't be beautiful :' 2 Republicans dissent as Trump's megabill narrowly passes
3/07/2025
